Arjun Sinha, MD
Advanced Heart Failure and Transplant Cardiology · Chicago, ILNPI 1255673935
Payments from drug & device makers
What this record shows
This record is dominated by grants: $5,000 of the $7,458 with a category attached, or 67.0%. Medtronic accounts for 67.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $6,875 and has fallen 99.2% since, to $57 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in IL, where the typical reported total is $11,038.
Across 27 payments — averaging $276.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$2K
- Cvrx, Inc.$92
- Impulse Dynamics (USA) Inc.$35
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$22
What the payments were for
- Grants$5,00067%
- Travel & lodging$98213%
- Food & beverage$1,47720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $5,000 |
| Abbott | 20 | $2,309 |
| Cvrx, Inc. | 3 | $92 |
| Impulse Dynamics (USA) Inc. | 2 | $35 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,458 in reported general payments places this provider in the 35th percentile of 56 advanced heart failure and transplant cardiology providers in Illinois.
See all advanced heart failure and transplant cardiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 60 | $1,685,195 |
| EntrestoSacubitril/Valsartan | 171 | $222,382 |
| JardianceEmpagliflozin | 127 | $189,817 |
| EliquisApixaban | 145 | $184,917 |
| OzempicSemaglutide | 16 | $15,565 |
| XareltoRivaroxaban | 14 | $14,759 |
| VeltassaPatiromer Calcium Sorbitex | 12 | $12,028 |
| LokelmaSodium Zirconium Cyclosilicate | 12 | $9,767 |
| BrilintaTicagrelor | 12 | $7,879 |
| Metoprolol Succinate | 259 | $4,720 |
| Tacrolimus | 26 | $3,775 |
| Bumetanide | 92 | $3,342 |
| Midodrine Hcl | 22 | $2,109 |
| Spironolactone | 225 | $1,837 |
| Ezetimibe | 34 | $1,716 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Chicago
- Jonathan RichChicago$327K
- Esther VorovichChicago$224K
- Jane WilcoxChicago$220K
- Manreet KanwarChicago$162K
- Jonathan GrinsteinChicago$128K
- Bow ChungChicago$86K
- Quentin YoumansChicago$75K
- Anjan TibrewalaChicago$58K
- Faraz AhmadChicago$36K
- Ike OkwuosaChicago$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.